Devises / PCRX
PCRX: Pacira BioSciences Inc
26.67
USD
0.18
(0.67%)
Le taux de change de PCRX a changé de -0.67% aujourd'hui. Au cours de la journée, l'instrument a été échangé à un minimum de 26.17 et à un maximum de 26.95.
Suivez la dynamique Pacira BioSciences Inc. Les cotations en temps réel vous aideront à réagir rapidement aux changements du marché. En basculant entre différentes périodes, vous pouvez surveiller les tendances et la dynamique des taux de change par minutes, heures, jours, semaines et mois. Utilisez ces informations pour prévoir les changements du marché et prendre des décisions de trading éclairées.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
PCRX Nouvelles
- PharmaCorp Rx completes fourth pharmacy acquisition for $2.4 million
- Pacira (PCRX) Q2 Revenue Rises 1.7%
- Pacira earnings beat by $0.02, revenue fell short of estimates
- Here's What Key Metrics Tell Us About Pacira (PCRX) Q2 Earnings
- Pacira (PCRX) Tops Q2 Earnings Estimates
- Pacira Q2 2025 slides: Revenue growth accelerates, margins expand amid strategic progress
- Pacira BioSciences: Worth Pondering, Strong Balance Sheet (NASDAQ:PCRX)
- Pacira BioSciences announces workforce reduction and facility changes
- PharmaCorp to acquire Western Canada pharmacy for $2.4 million
- Pacira BioSciences Debuts Inspiring New Film Highlighting One Patient’s Journey to Pain Relief and Innovation in Care at BIO 2025
- Impax Small Cap Fund Q1 2025 Commentary (Mutual Fund:PXSAX)
- Pacira BioSciences Unveils Three-Year Clinical Data Following a Single Local Administration of Investigational Gene Therapy, PCRX-201, in Patients with Moderate-to-Severe Osteoarthritis of the Knee
- Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Grabar Law Office Investigates Claims on Behalf of Shareholders of Pacira Biosciences Inc. (PCRX)
- Pacira at RBC Conference: Strategic Growth and Gene Therapy Focus
- Pacira reports promising gene therapy data for knee osteoarthritis
- Pacira BioSciences soars 52% following InvestingPro’s October Fair Value alert
- Wolverine World Wide, Pacira BioSciences And Other Big Stocks Moving Higher On Monday - Beam Therapeutics (NASDAQ:BEAM), B2Gold (AMEX:BTG)
- Pacira BioSciences Remains A 'Buy' For Pain Management With The NOPAIN Act
- Pacira Settles Patent Dispute Over Exparel With Fresenius, Delays Pain Med' Generics Entry Until 2030, Stock Jumps - Pacira BioSciences (NASDAQ:PCRX)
- Marvell Technology, Nvidia, Tesla, Apple And Other Big Stocks Moving Higher On Tuesday - Apple (NASDAQ:AAPL), Applied Optoelectronics (NASDAQ:AAOI)
- After-hours movers: Broadcom, Levi, Human and more
- Pacira BioSciences stock surges on patent litigation settlement
- Impax Small Cap Fund Q4 2024 Commentary
Range quotidien
26.17
26.95
Range Annuel
12.62
27.64
- Clôture Précédente
- 26.85
- Ouverture
- 26.90
- Bid
- 26.67
- Ask
- 26.97
- Plus Bas
- 26.17
- Plus Haut
- 26.95
- Volume
- 1.428 K
- Changement quotidien
- -0.67%
- Changement Mensuel
- 26.46%
- Changement à 6 Mois
- 11.36%
- Changement Annuel
- 74.31%
31 août, dimanche